Scott A. Soefje PharmD

PubMed

• Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
  Jennifer P Booth, Julie M Kennerly-Shah, Lindsey R Kelley, Donna Capozzi, Hillary A Prescott
  Journal of Oncology Pharmacy Practice. 2023-12-01
• 5 citations
  Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.
  Scott A Soefje, Corinne Carpenter, Katherine Carlson, Samir Awasthi, Thomas S Lin
  JCO Oncology Practice. 2023-04-01
• 1 citations
  Neulasta Onpro: a coup de grâce?
  Chelsee J Jensen, Caleb J Scheckel, Ronald S Go, Aakash Desai, Scott A Soefje
  The American Journal of Managed Care. 2023-03-01

Journal Articles

• Maximize Safety in the IV Compounding Process  
  Soefje SA, Pharmacy Purchasing & Products, 1/1/2017
• Pharmacists: Integral to the Management of Chemotherapy-Induced Nausea and Vomiting  
  Jupp J, Pasetka M, Soefje SA, Schwartz RN, J Clin Oncol, 1/1/2016
• Considerations for CSTD Use  
  Soefje SA, Pharmacy Purchasing & Products, 1/1/2016
• CSTD Training Tips  
  Soefje SA, Pharmacy Purchasing & Products, 1/1/2015
• Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy  
  Lu J, Lee-Gabel L, Nadeau MC, Ferencz TM, Soefje SA, J Oncol Pharm Pract, 1/1/2015
• These are Life-Saving Drugs I'm Not Going To Stop Treating Patients, Right?  
  Soefje SA, Cancer Letter, 1/3/2014
• Using lean methodology to improve productivity in a hospital oncology pharmacy  
  Sullivan P, Soefje SA, Reinhart, D, McGeary G, Cabie ED, Am J Health-Sys Pharm, 1/1/2014
• Launching Oncology IT System With Old + New Tech a Bad Idea  
  Soefje SA, Bubalo J, Clinical Oncology News, 1/1/2013
• Management of Oncolytic Viruses in Pharmacy  
  Soefje SA, Pharmacy Purchasing & Products, 1/1/2013
• Oncology Pharmacy: Designing Pathways and Guidelines for Disease Management in Cancer Center Profile: Smilow Cancer Hospital at Yale New Haven  
  Soefje SA, The Oncology Pharmacist, 1/1/2013
• Commentary: Dosing Chemotherapy in Obese Patients: No Clear Answers, Yet  
  Soefje SA, J Hemtol Oncol Pharm, 1/1/2011
• Bevacizumab in Metastatic Breast Cancer: Ready For Prime Time?  
  Mandock K, Soefje SA, Adams VR, J Hemtol Oncol Pharm, 1/1/2011
• Common toxicities for mTOR inhibitors  
  Soefje SA, Brenner A, Karnad A, Target Oncol, 1/1/2011
• Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic  
  McKee M, Frei BL, Garcia A, Fike D, Soefje SA, J Oncol Pharm Pract, 1/1/2011
• Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products  
  Zock MD, Soefje SA, Rickabaugh K, J Oncol Pharm Pract, 1/1/2011
• Risk Evaluation and Mitigation Strategies: Survey Results  
  Soefje SA, Hematology/Oncology Pharmacy Association (HOPA) Newsletter, 1/1/2010
• Update on Castration Resistant Prostate Cancer: A Review of Systemic Innovations  
  McKee M, Garcia AA, Frei BL, Soefje SA, The Oncology Pharmacist, 1/1/2010
• New formulation of Taxotere� reduces preparation time and supports the physical stability of the product in infusion bags: Data from the RELIUS international observati...  
  Pinguet F, Agustin MJ, Brown P, Soefje SA, Needleman R, Sanchez MN, Sommer U, Tranter B, Eur J Hosp Pharm, 1/1/2009
• Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant  
  Sankhala KK, Pandya DM, Sarantopoulos J, Soefje SA, Giles FJ, Chawla SP, Expert Opin Drug Metab Toxicol, 1/1/2009
• Introduction � Oncology, Part 1  
  Soefje SA, Mays T, Walsh-Chocolaad T, J Pharm Practice, 1/1/2008
• Introduction � Oncology, Part 2  
  Soefje SA, Mays T, Walsh-Chocolaad T, J Pharm Practice, 1/1/2008
• A Review of the Cardiovascular Effects of Oncology Agents  
  Frei BL, Soefje SA, J Pharm Practice, 1/1/2008
• Prostate Cancer  
  Grabinski J, Soefje SA, Texas Pharmacy, 1/1/2003
• Pain Management: A Pharmacological Approach  
  Soefje SA, Texas Pharmacy, 1/1/2001
• The rational use of opioids in the elderly cancer patient  
  Osborne C, Soefje SA, Mathew P, Annals of Longterm Care: Clinical Care and Aging, 1/1/2000
• Join now to see all

Books/Book Chapters

• PSAP IV 
  Chapter: Lung Cancer 
  Soefje SAACCP2003

Abstracts/Posters

• Innovative Method for Remote Site BCG Distribution
  Szewcyk, MT, Kansagra S, Cabie E, Soefje SA, Paci G, Joseph A. Zacagino Safety and Clinical Quality Conference, New Haven, CT, 1/1/2014
• Evaluation of Methadone and QTc Prolongation: Developing a Risk Stratification in Cancer Patients
  Wong M, Pham T, Soefje SA, HOPA Annual Meeting, New Orleans, LA, 1/1/2014
• The Use of Basiliximab-Infliximab Combination for the Treatment of Steroid Refractory Acute Graft Versus Host Disease (aGVHD)
  Nadeau M, Perreault S, Soefje SA, Cooper D, HOPA Annual Meeting, New Orleans, LA, 1/1/2014
• Cost-Effectiveness Analysis of Transitioning Rituximab Infusions to an Outpatient Setting
  Perreault S, Patel K, Brekhman A, Cooper D, Lee AI, Soefje SA, HOPA Annual Meeting; J Oncol Pharm Pract, New Orleans, LA, 1/1/2014
• Developing a Voriconazole Dose Modification Guideline to Optimize Therapeutic Levels in Patients with Hematologic Malignancies
  Lin T, Perreault S, Soefje SA, Topal J, HOPA Annual Meeting, New Orleans, LA, 1/1/2014
• Identifying and targeting risk factors for readmission in a medical oncology unit: a two-phase investigation
  Luon D, Chaar R, Mandock K, Merl MY, Ha M, Soefje SA, ASHP Annual Meeting, Orlando, FL, 1/1/2013
• Implementation of a pharmacist � driven oral chemotherapy counseling program at an academic medical center: a pilot program
  Ledbetter LE, Tuttle LA, Kansagra SA, Soefje SA, ASHP Annual Meeting, Orlando, FL, 1/1/2013
• Romidepsin-Associated Cardiac Toxicities in the Treatment of T-Cell Lymphoma
  Mangini N, Perreault S, Soefje SA, Barbarotta L, Foss FL, HOPA Annual Meeting, Los Angeles, CA, 1/1/2013
• Assessing the Effectiveness of an Empiric Carboplatin Skin Testing and Desensitization Protocol
  Proli A, Nelson W, Abdelghany O, Soefje, SA, HOPA Annual Meeting, Los Angeles, CA, 1/1/2013
• Using LEAN methodology to improve productivity and safety in a hospital oncology pharmacy
  Sullivan P, Reinhart D, Soefje SA, McGeary C, Cabie, E, ASHP Clinical Midyear Meeting, Las Vegas, NV, 1/1/2012
• Assessing the Effectiveness of an Empiric Carboplatin Skin Testing and Desensitization Protocol
  Proli A, Nelson W, Soefje SA, ASHP Clinical Midyear Meeting, Las Vegas, NV, 1/1/2012
• Telepharmacy: a state approved pilot project
  Cabie ED, Beaulieu N, Soefje SA, Cohen H, Lee L, The Joseph A. Zaccagnino Safety and Clinical Quality Conference, New Haven, CT, 1/1/2012
• Developing a Predictive Model to Assess Cardiotoxic Risk and Determine the Indication for Baseline Cardiac Monitoring for Patients Treated with Anthracyclines
  Mandock, K, Nelson, WK, Abdelghany O, Coleman CI, Soefje SA, HOPA Annual Meeting, Orlando, FL, 1/1/2012
• Measuring the potential impact on drug expenditures through the use of a pharmacy-based Medication Assistance Program (MAP) at an academic cancer hospital
  Jacob S, Lazarre M, Miller LA, Soefje SA, American Society of Health-Systems Midyear Clinical Meeting, New Orleans, LA, 1/1/2011
• Assessing health literacy in outpatient oncology patients at an academic medical center
  Mangini NS, Mandock K, Govani S, Soefje SA, American Society of Health-Systems Midyear Clinical Meeting, New Orleans, LA, 1/1/2011
• Impact of Clinical Oncology Pharmacy Service on Patients in an Outpatient Clinic
  McKee M, Garcia A, Frei B, Fike D, Soefje SA, HOPA Annual Meeting, New Orleans, LA, 1/1/2010
• A phase II study of intravenous REOLYSIN (Wild type reovirus) in the treatment of patients with bone and soft tissue sarcomas metastatic to the lung
  Soefje SA, Sarantopoulos J, Sankhala K, Mita CA, Mahany JJ, Carmona T, Coffey M, Gill GM, Mettinger K, Mita MM, Proc Am Soc Clin Oncol.; Pharmcotherapy, 1/1/2008
• Efficacy of fluconazole prophylaxis for autologous peripheral blood stem cell transplantation (PBSCT): A prospective, randomized, multicenter, open-label study
  Shah S, Walsh T, Soefje SA, Williams C, Texas Society of Health-System Pharmacists 54th Annual Seminar, 1/1/2002
• Randomized comparison of different dosing schedules for epoetin alfa in patients with chemotherapy related anemia
  Williams CB, Soefje SA, Walsh TL, Shah S, Pollock B, Garcia AA, Murillo JR, Nelsen AC, Texas Society of Health-System Pharmacists 54th Annual Seminar; 12th Annual Symposium on Cancer Research in San Antonio, San Antonio, TX, 1/1/2002
• Impact of cancer pain treatment guidelines at the South Texas Veterans Healthcare System: a preliminary report
  Soefje SA, Chung D, Walsh TL, Klementich F, Sheridan-Leos N, Thomas CR, Proc Am Soc Clin Oncol, 1/1/2002
• Randomized comparison of different dosing schedules for epoetin alfa in patients with chemotherapy related anemia
  Williams CB, Soefje SA, Walsh TL, Shah S, Garcia AA, Murillo JR, Nelsen AC, American Society of Health-Systems Midyear Clinical Meeting, New Orleans, LA, 1/1/2001
• Phase I trial of sequential high-dose carboplatin, topotecan and etoposide with autologous stem cell transplantation for refractory malignancies
  Carroll MP, Velasquez W, Li Z, Indrikovs A, Hatch S, Soefje SA, Fung FK, Blood, 1/1/2000
• A cost benefit analysis of pediatric clinical pharmacists
  Socier TL, Pham CM, Soefje SA, American Society of Health-Systems Midyear Clinical Meeting, Orlando, FL, 1/1/1999
• The pharmacokinetics of high-dose busulfan in breast cancer patients
  Soefje SA, Tran H, Fung FK, Madden T, Indrikows A, May WS, Carrol MP, Blood, 1/1/1999
• Combined rotational and longitudinal evaluation system utilizing the residency learning system
  Soefje SA, Scholz RL, ASHP National Residency Preceptors Conference, San Diego, CA, 1/1/1999
• Join now to see all

Lectures

• Cost of a Cure: Evaluating the Value of Care 
  1/27/2017
• An Update on the Use of Immunotherapy: A Look at Melanoma 
  The University of Texas at Austin College of Pharmacy, Austin, TX - 1/16/2017
• Updates for Advanced Melanoma 
  Orlando, FL - 1/15/2017
• Cost of a Cure: The Rising Cost of Medications 
  Round Rock, TX, 2016; The University of Texas at Austin College of Pharmacy, Houston, TX, 2017 - 1/9/2017
• Hospital Pharmacy Practice and Pharmacy Management 
  1/1/2016
• Implementing an Electronic Medical Record: Five Things Every Pharmacist Should Know 
  Chicago, IL - 1/27/2013
• Carboplatin: Time to Drop the Curtain on the Dosing Debate 
  Los Angeles, CA - 1/22/2013
• Health Care Reform: Five Things Every Pharmacist Should Know 
  Trumball, CT - 1/12/2013
• Prevention of Chemotherapy Induced Nausea and Vomiting: A Pharmacist Perspective 
  Women�s and Infant�s Hospital, Providence, RI - 1/28/2012
• Updates in the Treatment of Colon Cancer 
  Boston, MA - 1/26/2012
• Evaluating Response Criteria in Oncology Research 
  Orlando, FL - 1/23/2012
• BSA: Good Science or Bad Habit? 
  St. Louis, MO, 2006; Yale New Haven Hospital, New Haven, CT, 2012 - 1/16/2012
• Equivalence Trials and Innovative Trial Designs in Oncology Research 
  Yale New Haven Hospital, New Haven, CT - 1/6/2012
• Drug Accountability 
  1/1/2011
• Safe Handling of Hazardous Drugs 
  Nashville, TN, 2009; Hiroshima, Japan, 2010 - 1/8/2010
• FDA Drug Approval Process 
  San Antonio, TX - 1/14/2009
• Prophylaxis of Deep Vein Thrombosis in Medical Patients with Severely Restricted Mobility During Acute Illness 
  Austin, TX - 1/12/2009
• Pain Management: Making a Difference 
  San Antonio, TX - 1/11/2009
• Clinical Update of EGFR Inhibitors: Focus on Panitumumab 
  Lubbock, TX - 1/7/2009
• Investigational Drug Services 
  Anaheim, CA - 1/18/2008
• Hazardous Drug Exposure: Risks and Current Guidelines 
  Orlando, FL - 1/10/2008
• Safe Handling of Hazardous Chemotherapeutic Agents: Effective Strategies for Risk Containment 
  Orlando, FL - 1/10/2008
• The Changing Endpoints and Outcomes in the Oncology Drug Approval Process 
  Anaheim, CA, 2008; Louisville, KY, 2008; Orlando, FL, 2008 - 1/9/2008
• Controversies in Oncology Pharmacy Practice Weight Based Dosing vs. Fixed Dosing 
  St. Louis, MO - 1/27/2006
• Targeted Therapies in Oncology 
  The University of Texas, Austin, TX - 1/16/2006
• Join now to see all